Marie‐Therese Schaeffer

Author

Merck & Co., Inc., Rahway, NJ, USA (United States)

Also Known As

M T Schaeffer, M. T. Schaeffer, M.T. Schaeffer, MA Schaeffer, MARIE‐THERESE SCHAEFFER, Marie-Therese Schaeffer, Marie‐Therese Schaeffer, Melissa Crisp

Publications

Citations

H-Index

Concepts

All Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)Scripps Research Institute

About

Marie‐Therese Schaeffer is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, pharmacology, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	17	727
2	Biochemistry	11	13	395
3	Natural Sciences	6	6	218
4	Cell Biology	4	4	417
5	Health Sciences	1	1	223

Marie‐Therese Schaeffer

Publications

972

Citations

H-Index

Page 1

	Year	Citations
Purification of a glycoprotein vascular endothelial cell mitogen from a rat glioma-derived cell line. Greg Conn, D.D. Soderman, Marie‐Therese Schaeffer, Proceedings of the National Academy of Sciences Glioma-derived Growth FactorCell ProliferationGliomaCellular PhysiologyTumor Biology	1990	223
Full Pharmacological Efficacy of a Novel S1P1 Agonist That Does Not Require S1P-Like Headgroup Interactions Pedro J. Gonzalez‐Cabrera, Euijung Jo, Marta Sanna, Molecular Pharmacology	2008	120
Conversion of cysteine to serine residues alters the activity, stability, and heparin dependence of acidic fibroblast growth factor. Sagrario Ortega, Marie‐Therese Schaeffer, D.D. Soderman, Journal of Biological Chemistry Mitogenic ActivityCell ProliferationCytoskeletonCell GrowthCellular Physiology	1991	103
Actions of a picomolar short-acting S1P1 agonist in S1P1-eGFP knock-in mice Stuart M. Cahalan, Pedro J. Gonzalez‐Cabrera, Gor Sarkisyan, Nature Chemical Biology Knockout MouseMolecular PharmacologyMolecular NeuroscienceMolecular PhysiologySignal Transduction	2011	79
Disulfide Bonds are Neither Required, Present, Nor Compatible with Full Activity of Human Recombinant Acidic Fibroblast Growth Factor David L. Linemeyer, John G. Menke, Linda Kelly, Growth Factors	1990	63
Molecular Basis of the Pharmacological Difference between Rat and Human Bombesin Receptor Subtype-3 (BRS-3) Jie Liu, Zhege Lao, Marie‐Therese Schaeffer, Biochemistry	2002	62
Synthesis and activity of 4,5-diarylimidazoles as human CB1 receptor inverse agonists Christopher W. Plummer, Paul E. Finke, Sander G. Mills, Bioorganic & Medicinal Chemistry Letters Molecular PharmacologyDrug TargetBiochemistryFunctional SelectivityMedicine	2005	56
Discovery, synthesis and SAR analysis of novel selective small molecule S1P4-R agonists based on a (2Z,5Z)-5-((pyrrol-3-yl)methylene)-3-alkyl-2-(alkylimino)thiazolidin-4-one chemotype Mariangela Urbano, Miguel Guerrero, Subash Velaparthi, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryThiazolidin-4-one ChemotypeDrug TargetBiochemistryNatural Sciences	2011	38
Discovery, design and synthesis of the first reported potent and selective sphingosine-1-phosphate 4 (S1P4) receptor antagonists Miguel Guerrero, Mariangela Urbano, Subash Velaparthi, Bioorganic & Medicinal Chemistry Letters BiochemistryMedicineReceptor AntagonistsReceptor (Biochemistry)Pharmacology	2011	36
Synthesis and SAR of 5,6-diarylpyridines as human CB1 inverse agonists Laura C. Meurer, Paul E. Finke, Sander G. Mills, Bioorganic & Medicinal Chemistry Letters Molecular PharmacologyMedicinal ChemistryBiochemistryFunctional SelectivityMedicine	2004	33

Page 1